Articles From: Coeur Announces Commencement of Exchange Offer to Free Checking Down, ATM and Overdraft Fees Up -- But Only Slightly

Coeur Mining, Inc. (“Coeur” or the “Company”) (NYSE:CDE, TSX:CDM) today announced its offer to exchange certain of its outstanding unregistered notes for new registered notes in accordance with the terms of its registration rights agreement with existing holders of those notes.
Sign-up for Coeur Announces Commencement of Exchange Offer investment picks
AGCO, Your Agriculture Company (NYSE: AGCO), a worldwide manufacturer and distributor of agricultural equipment, is launching a new retail finance program for its customers in Central Europe.
Sign-up for AGCO Launches Retail Finance Solutions in Central Europe investment picks
Norsat International Inc. (“Norsat” or the “Company”) (TSX: NII and OTC QB: NSATF) , a leading provider of innovative communication solutions that enable the transmission of data, audio and video for remote and challenging applications, is pleased to announce the launch of the 1.2m Ku-band all-in-one VSAT Bundle.
Sign-up for Norsat Launches Commercial Grade 1.2m Ku-band All-in-One VSAT Bundle investment picks
Protalex, Inc. (OTCBB:PRTX), a clinical-stage biopharmaceutical company, today announced that two posters relating to PRTX-100, the Company’s investigational drug, were accepted for presentation at the 2013 American College of Rheumatology ARHP Annual Meeting, to be held at the San Diego Convention Center from October 25 – 30, 2013.
Sign-up for Protalex Announces Two Posters Accepted for Presentation at 2013 American College of Rheumatology Annual Meeting investment picks
Sign-up for KaloBios to Present at Leerink Swann Rare Disease Roundtable investment picks
KB Home (NYSE: KBH), one of the nation's largest and most recognized homebuilders, today announced that it has acquired property at 72 Townsend in San Francisco and has started construction on a highly-anticipated nine-story glass and steel frame luxury condominium building.
Sign-up for KB Home to Construct Mid-Rise Luxury Condo Building in San Francisco investment picks
Sign-up for MELA Sciences, a Leader in the Fight Against Melanoma, Appoints Tony Dimun to Its Board of Directors investment picks
DCU Leading Consortium of 36 Credit Unions to Support SunPower Loan Program SAN JOSE, Calif.
Sign-up for Digital Federal Credit Union to Offer Up to $100 Million in Loans for SunPower Residential Solar Systems investment picks
Expanded Portfolio of IP Cores Enhanced with 15 Percent Timing Margin for Faster Design Integration SAN JOSE, Calif.
Sign-up for Altera Completes Latest Upgrade to IP Portfolio Targeting 28 nm Devices investment picks
Sign-up for BioMed Realty Increases Capacity Under Credit Facility To $1.25 Billion investment picks
Sign-up for Shanda Group is Among the First to Access China (Shanghai) Pilot Free Trade Zone investment picks
WUHAN, China , Sept.
Sign-up for Tianli Agritech, Inc. Announces $3.2 Million Private Placement Transaction investment picks
September 30, 2013: Nautilus, Inc. (NYSE: NLS), a leader in innovative home fitness equipment, today unveiled new designs and functionality for a new suite of Schwinn® cardio equipment.
Sign-up for Nautilus Inc. Launches All New Line Up of Schwinn® Cardio Products investment picks
Sign-up for Vimicro International Receives Order for Major SVAC Video-Surveillance Deployment in Sichuan Province investment picks
ServiceSource® (NASDAQ: SREV), the global leader in recurring revenue management, today announced its platinum sponsorship of’s Dreamforce 2013 conference ( ), November 18-21 at the Moscone Center in San Francisco.
Sign-up for ServiceSource Announces Platinum Sponsorship of Dreamforce 2013 investment picks
DALIAN, China , Sept.
Sign-up for V Media Corp. Announces Fiscal 2013 Year End Financial Results investment picks
Lion Biotechnologies, Inc. (OTCBB: GNBPD) is providing updated results from a Phase II trial for metastatic melanoma conducted by the National Cancer Institute (NCI) utilizing the tumor-infiltrating lymphocyte (TIL) technology currently licensed by the Company and being developed under a Cooperative Research and Development Agreement (CRADA) with the NCI.
Sign-up for Lion Biotechnologies Provides Update on Phase II Results for Metastatic Melanoma investment picks
Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, announced today that it has completed enrollment in its Phase II trial with ALN-TTR02, an RNAi therapeutic targeting the transthyretin (TTR) gene for the treatment of TTR-mediated amyloidosis (ATTR). Recent interim results from this Phase II study showed that ALN-TTR02 achieved up to 93% knockdown of TTR – the disease-causing protein in ATTR.
Sign-up for Alnylam Completes Enrollment of Phase II Clinical Trial and Initiates Open-Label Extension (OLE) Study with ALN-TTR02, an RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of Transthyretin-Mediated Amyloidosis (ATTR) investment picks
- Isavuconazole phase 3 invasive aspergillosis study (SECURE) meets primary endpoint - TOKYO , Sept.
Sign-up for Astellas reports positive topline phase 3 results for antifungal isavuconazole investment picks
Knight Transportation, Inc. (NYSE:KNX)(“Knight”), one of North America’s largest and most diversified truckload transportation companies, today issued the following statement regarding USA Truck, Inc.’s (NASDAQ:USAK) rejection of Knight’s $9.00 per share, all-cash, premium proposal: Knight also announced today that it has filed with the U.S. Securities and Exchange Commission an amendment to its Schedule 13D, originally filed on September 26, 2013, disclosing an increased ownership position of 1,192,364 shares of USA Truck common stock, representing approximately 11.3% of USA Truck’s shares outstanding.
Sign-up for Knight Transportation Responds to USA Truck’s Rejection of $9.00 Per Share All-Cash, Premium Proposal investment picks
Company Fosters Collaboration, Creativity to Build on Award-Winning e-Commerce Business and Digital Innovation NAPERVILLE, Ill.
Sign-up for OfficeMax Chief Digital Officer Elected to Board investment picks
BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCBB:BRTX) , a life sciences company focused on developing stem cell-based therapies for personal medical applications, announced the engagement of the regulatory consultancy firm Phil Triolo and Associates, LC (“PTA”) to help advance the Company’s brtxDISC™ therapeutic procedure through the U.S. Food and Drug Administration (“FDA”) regulatory process.
Sign-up for BioRestorative Engages Consulting Firm to Advance brtxDISC™ Program Delivery Device through FDA Clearance Process investment picks
Sign-up for Ampio Pharmaceuticals, Inc. Announces Additional Positive Results for Ampion(TM) in Osteoarthritis of the Knee Clinical Trial investment picks
GE Capital, Corporate Finance today announced it is administrative agent and sole lender on a $110 million asset-based credit facility for Arthur Schuman, Inc., a leading cheese manufacturer and distributor.
Sign-up for GE Capital Provides $110 Million to Arthur Schuman, Inc. investment picks
Sign-up for Entropic Discusses Advantages of Next-Generation Silicon Platforms for the Connected Home investment picks
ACI Worldwide (NASDAQ: ACIW), a leading international provider of electronic payment systems, today announced ACI Bill Presentment Services , a new outsourced offering that provides electronic bill presentment tailored for the unique needs of organizations in consumer finance, insurance and utilities.
Sign-up for ACI Worldwide Provides Fresh Approach to Lowering Paper Bill Postage and Printing Expenses investment picks
FAIRLAWN, Ohio , Sept.
Sign-up for OMNOVA Solutions Reports Improved Third Quarter 2013 Results investment picks
SNC-Lavalin Initiates Process to Sell an Equity Stake in AltaLink Canada NewsWire MONTREAL , Sept.
Sign-up for SNC-Lavalin Initiates Process to Sell an Equity Stake in AltaLink investment picks
Sign-up for Global Links Signs Agreement With the Nation of Sierra Leone to Launch Affordable Housing Initiative investment picks
NEW YORK , Sept.
Sign-up for Free Checking Down, ATM and Overdraft Fees Up -- But Only Slightly investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar

Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Coeur Announces Commencement of Exchange Offer to Free Checking Down, ATM and Overdraft Fees Up -- But Only Slightly
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity